C30H25F3N4O4 — CID 10120430
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-2-[(5S)-2-oxo-5-phenyl-1-[(2,3,6-trifluorophenyl)methyl]-3,4-dihydro-1,4-benzodiazepin-5-yl]acetic acid (PubChem CID 10120430) has the molecular formula C30H25F3N4O4 and a molecular weight of 562.55 g/mol. Its IUPAC name is (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-2-[(5S)-2-oxo-5-phenyl-1-[(2,3,6-trifluorophenyl)methyl]-3,4-dihydro-1,4-benzodiazepin-5-yl]acetic acid.
| Compound Name | (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-2-[(5S)-2-oxo-5-phenyl-1-[(2,3,6-trifluorophenyl)methyl]-3,4-dihydro-1,4-benzodiazepin-5-yl]acetic acid |
|---|---|
| PubChem CID | 10120430 |
| Molecular Formula | C30H25F3N4O4 |
| Molecular Weight | 562.55 g/mol |
| Exact Mass | 562.18 |
| IUPAC Name | (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-2-[(5S)-2-oxo-5-phenyl-1-[(2,3,6-trifluorophenyl)methyl]-3,4-dihydro-1,4-benzodiazepin-5-yl]acetic acid |
| SMILES | Cc1cc(C)nc(O[C@H](C(=O)O)[C@@]2(c3ccccc3)NCC(=O)N(Cc3c(F)ccc(F)c3F)c3ccccc32)n1 |
| InChI | InChI=1S/C30H25F3N4O4/c1-17-14-18(2)36-29(35-17)41-27(28(39)40)30(19-8-4-3-5-9-19)21-10-6-7-11-24(21)37(25(38)15-34-30)16-20-22(31)12-13-23(32)26(20)33/h3-14,27,34H,15-16H2,1-2H3,(H,39,40)/t27-,30+/m1/s1 |
| InChIKey | NKONTEUZTOHVNH-OFSOJUDTSA-N |
| XLogP | 4.42 |
| TPSA | 104.65 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 562.55 |
| LogP ≤ 5 | 4.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'} |
|---|